Dan Cui
Impact in
- Neurology top 2%
- Long-Term Effects of COVID-19
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- SARS-CoV-2 detection and testing
Papers in
-
- SARS-CoV-2 and COVID-19 Research 6
- COVID-19 Clinical Research Studies 5
-
- Hepatocellular Carcinoma Treatment and Prognosis 8
- Co-authors
- Zongfu Mao (14 shared papers)Lixue Huang (5 shared papers)Ying Yang (7 shared papers)Yeming Wang (5 shared papers)Bin Cao (6 shared papers)Xiaoying Gu (3 shared papers)Lianhan Shang (2 shared papers)Jianwei Wang (2 shared papers)
- Journals
- Scientific Reports (5 papers)PLoS ONE (4 papers)Frontiers in Pharmacology (4 papers)Frontiers in Public Health (3 papers)BMC Public Health (3 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Dan Cui
138 papers receiving 3.6k citations
Dan Cui's Hit Papers
Peers
Comparison fields: 5 of 169
- Neurology 611
- Infectious Diseases 668
- Applied Microbiology and Biotechnology 54
- Pharmacology 226
- Critical Care and Intensive Care Medicine 114
Countries citing papers authored by Dan Cui
This map shows the geographic impact of Dan Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dan Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dan Cui more than expected).
Fields of papers citing papers by Dan Cui
This network shows the impact of papers produced by Dan Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dan Cui. The network helps show where Dan Cui may publish in the future.
Co-authors
The 25 scholars most cited alongside Dan Cui, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 147 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Health outcomes in people 2 years after surviving hospitalisation with COVID-19: a longitudinal cohort study Hit paper breakdown → | 2022 | 433 |
| 2 | SARS-CoV-2 spike D614G change enhances replication and transmission Hit paper breakdown → | 2021 | 380 |
| 3 | EGFR activation limits the response of liver cancer to lenvatinib Hit paper breakdown → | 2021 | 354 |
| 4 | 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study Hit paper breakdown → | 2023 | 253 |
| 5 | 2001 | 107 | |
| 6 | 2007 | 98 | |
| 7 | 2013 | 93 | |
| 8 | 2014 | 80 | |
| 9 | 2005 | 67 | |
| 10 | 2021 | 58 | |
| 11 | 2024 | 56 | |
| 12 | 2020 | 55 | |
| 13 | 2020 | 51 | |
| 14 | 2007 | 49 | |
| 15 | 2013 | 46 | |
| 16 | 2021 | 42 | |
| 17 | 2022 | 40 | |
| 18 | 2022 | 36 | |
| 19 | 2015 | 34 | |
| 20 | 2017 | 34 |
About Dan Cui
Dan Cui is a scholar working on Infectious Diseases, Hepatology, Neurology, Molecular Biology and Epidemiology, having authored 147 papers that have together received 3.7k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (8 papers), Long-Term Effects of COVID-19 (8 papers), Neuroendocrine regulation and behavior (6 papers), SARS-CoV-2 and COVID-19 Research (6 papers), Global Education and Multiculturalism (5 papers), COVID-19 and Mental Health (5 papers), COVID-19 Clinical Research Studies (5 papers) and Pharmaceutical Economics and Policy (5 papers). The work is most often cited by research in Neurology (611 citations), Infectious Diseases (668 citations), Applied Microbiology and Biotechnology (54 citations), Pharmacology (226 citations) and Critical Care and Intensive Care Medicine (114 citations). Dan Cui has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Zongfu Mao, Lixue Huang, Ying Yang, Yeming Wang, Bin Cao, Xiaoying Gu, Lianhan Shang, Jianwei Wang, Jingchuan Zhong and Xueyang Zhang. Their work appears in journals such as Scientific Reports, PLoS ONE, Frontiers in Pharmacology, Frontiers in Public Health and BMC Public Health.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.